Viemed (VMD) insider filing shows RSU vesting and cash settlement at $7.31

Rhea-AI Filing Summary

On 08/22/2025 Viemed Healthcare director and General Counsel Jeremy Trahan experienced equity award activity tied to prior grants. 2,986 cash-settled phantom share units vested and were reported as a cash settlement and simultaneous disposition of the underlying shares at a per-share value of $7.31. 5,971 Restricted Stock Units vested and converted into common shares, with 1,634 of those shares withheld to satisfy tax withholding. The reporting person holds 25,503 common shares following these transactions.

Positive

• Vesting executed as scheduled: 5,971 RSUs and 2,986 phantom units vested consistent with the grant terms.
• Transparent disclosure: The Form 4 reports cash settlement value per share at $7.31 and tax-withholding shares, providing clear mechanics of the transactions.

Negative

• Net reduction in held shares due to tax withholding: 1,634 vested RSU shares were withheld to satisfy tax obligations.
• Cash settlement of phantom units reduces potential future upside: 2,986 units were settled for cash rather than converted into long-term-held shares.

Insights

Financial Analyst

TL;DR Routine executive equity vesting and tax withholding; limited market impact at reported sizes.

The Form 4 documents scheduled vesting events rather than open-market sales or discretionary purchases. The cash settlement of 2,986 phantom units at the closing price of $7.31 and the conversion of 5,971 RSUs into shares are internal compensation mechanics. The withholding of 1,634 shares for taxes reduces net share issuance to the reporting person but does not create new dilution beyond the plan terms. For investors this is information about insider compensation timing, not an operational development.

Corporate Governance Expert

TL;DR Compensation plan mechanics executed as designed; disclosures are complete and transparent.

The filing shows vesting schedules from awards originally granted on 08/22/2022 and vesting in three equal annual installments. The reporter used the appropriate Form 4 mechanics to show cash settlement of phantom units and share withholding for taxes. These actions align with standard governance practice for equity-based compensation and the form discloses the price basis used for the cash settlement.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Trahan Jeremy

(Last) (First) (Middle)

625 E. KALISTE SALOOM RD.

(Street)

LAFAYETTE LA 70508

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VIEMED HEALTHCARE, INC. [ VMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	08/22/2025		M		2,986	A	(1)	24,152	D
Common Shares	08/22/2025		D		2,986	D	$7.31(1)(2)	21,166	D
Common Shares	08/22/2025		M		5,971	A	(3)	27,137	D
Common Shares	08/22/2025		F		1,634(4)	D	$7.31(2)	25,503	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Share Units	(1)	08/22/2025		M			2,986	(5)	08/22/2025	Common Shares	2,986	(1)	0	D
Restricted Stock Units	(3)	08/22/2025		M			5,971	(6)	08/22/2025	Common Shares	5,971	$0	0	D

Explanation of Responses:

1. Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.

2. Per share value is based on the market closing price of the common shares for August 22, 2025.

3. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.

4. Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.

5. Represents an award granted on August 22, 2022 under the Issuer's Phantom Share Unit Plan which vested in three equal annual installments beginning on the first anniversary of the grant date.

6. Restricted Stock Units (RSUs) granted to reporting person on August 22, 2022, which vested in three equal annual installments beginning on the first anniversary of the grant date.

Remarks:

	/s/ Jesse Bergeron, Attorney-in-Fact	08/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Jeremy Trahan report on Form 4 for VMD?

The filing reports vesting and settlement on 08/22/2025: 2,986 phantom share units were cash-settled and 5,971 RSUs vested, with 1,634 RSU shares withheld for taxes.

How was the cash settlement value determined?

The per-share value used for the cash settlement is reported as $7.31, based on the market closing price for August 22, 2025.

How many Viemed common shares does the reporting person own after these transactions?

Following the reported transactions the reporting person beneficially owns 25,503 common shares (direct ownership).

Were these transactions open-market trades or compensation vesting events?

These transactions reflect compensation vesting events: cash settlement of phantom units and vesting/conversion of RSUs; they are not open-market discretionary trades.

When were the original awards granted that vested on 08/22/2025?

The phantom share units and RSUs were granted on 08/22/2022 and vested in three equal annual installments beginning on the first anniversary of the grant date.